{"version":"1.0","type":"link","title":"Efficacy, safety, and biomarkers of neoadjuvant trastuzumab and pertuzumab combined with chemotherapy in Chinese patients with HER2-positive breast cancer: a multicenter retrospective cohort study.","author_name":"Qi X 외","author_url":"https://prs-insight.online/author/Qi%20X","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/92122","thumbnail_width":1200,"thumbnail_height":630}